|
Contact
|
Newsletter
|
Deutsch
Subgroups
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Topics
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Press Contact
Bayer AG
(Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Photo-Service
Biographies
Board of Management
Subgroups
Speeches
Photos
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Education and Training
Research
Locations
Environmental Protection
BayKomm
TV Service
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Jobs and Career
Sports
General Conditions of Use
Privacy Statement
Imprint
Latest News
|
1 - 20
|
21 - 40
|
41 - 60
|
61 - 80
|
81 - 100
|
|
Thursday - September 4, 2008
Microstructured apparatus for the process industry
Novel, high-efficiency heat exchanger and reactor
Significantly greater heat transfer reduces apparatus and energy costs. Gentler on products
Thursday - September 4, 2008
Bayer CropScience AG:
Annual Press Conference 2008
Thursday - September 4, 2008
Setting the course after a very successful first half of 2008:
Bayer CropScience plans investment of EUR 3.4 billion in research and development through 2012
Expansion of R&D program will strengthen basis for future growth / Achievement of target EBITDA margin of around 25 percent already expected in 2008 / Sales target of EUR 2 billion with new active ingredients now envisaged for 2009 / Launch of 10 new crop protection compounds with a peak sales potential of more than EUR 1 billion planned through 2012
Wednesday - September 3, 2008
Industrial research of the highest scientific caliber:
Otto Bayer Medals awarded for outstanding research
Three research teams from Bayer commended for innovations in healthcare, nutrition and high-tech materials / Bayer has the highest level of research and development spending in the German chemical and pharmaceutical industry
Tuesday - September 2, 2008
Bayer launches “Bayer Cares Project” in China
Sustainable help for earthquake-stricken college in Sichuan
Donation of 20 classrooms, 50 homes and a mobile clinic
Tuesday - September 2, 2008
Bayer Submits Recombinant Human Thrombin for European Approval
Recothrom® would be the first recombinant human thrombin for use as a topical aid to surgical hemostasis in Europe
Sunday - August 31, 2008
Secondary prevention in acute coronary syndrome (ACS):
Rivaroxaban Phase II Data in ACS to be Presented at AHA Congress in November 2008
First data presentation from large dose-finding trial involving about 3,500 patients / Acceleration of clinical development in acute coronary syndrome planned
Friday - August 29, 2008
Environmentally compatible and economical:
Makrolon® sheets for climate-friendly building concepts
Friday - August 29, 2008
Online ordering for cost-effective procurement:
Bayer MaterialScience launches new plastics recyclate
Wednesday - August 27, 2008
New Bayer CropScience active ingredient approved in Romania:
Thiencarbazone-methyl registered in first market
Annual sales potential of more than EUR 100 million for new corn herbicide
Thursday - August 21, 2008
Bayer and Onyx continue clinical investigation of sorafenib:
New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer
Enrollment initiated in international phase III study
Thursday - August 21, 2008
Further expansion of activities in China:
Bayer MaterialScience starts construction of a world-scale TDI plant in Shanghai
Annual capacity of 250,000 metric tons approved / Capacity can be increased to 300,000 metric tons per year / Start-up planned for 2010
Tuesday - August 19, 2008
Bayer HealthCare and Regeneron Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-related Macular Degeneration
Study patients, on average, received only two additional doses following a 12-week fixed dosing period
Tuesday - August 19, 2008
German premiere for polyurethane railway ties in the Leverkusen CHEMPARK
A material that is very much on track
Better dimensional and weather stability than wood, lighter than concrete
Tuesday - August 19, 2008
Bayer Schering Pharma to support USAID with contraceptives for family planning programs
Access to family planning for more than 8 million women in developing countries / 110 million cycles of oral contraceptives to be provided each year
Tuesday - August 12, 2008
Excellence in the Field of Communications Honored
Bayer’s Annual Report Receives International Praise
Friday - August 8, 2008
Light, high-endurance manhole covers made of polyurethane sandwich composite
Hermetically sealed on the road
Thursday - August 7, 2008
Bayer Schering Pharma strengthens its oncology R&D portfolio
Bayer acquires Preclinical Anti-cancer Program from Nycomed
Company assuming full development and commercialization rights
Tuesday - August 5, 2008
Bayer MaterialScience raises price for MDI
Tuesday - August 5, 2008
Makrolon® from Bayer MaterialScience for the German Embassy in Beijing:
“inForm” art installation – in peak condition for the Olympics
|
1 - 20
|
21 - 40
|
41 - 60
|
61 - 80
|
81 - 100
|
|
Print page
Search
Advanced Search
Publications
Stockholder's Newsletter
Annual Report 2007
Sustainable Development Report 2007
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
We will keep you informed about the latest news.
Events
Wednesday, October 29, 2008
Q3 2008 Interim Report
Contact:
Günter Forneck
Additional Press Events
Investor Relations Events
Sport Events
BayKomm Events
Download Center - Selection
Your selection:
0
Download(s)
Bayer TV
TV Service Platform
TV Service:
Bayer Climate Program